Drug trial halted due to contractor GMP violations; Pfizer seeks "redundancy" volunteers in Ireland;

> A clinical trial of RegeneRx Biopharmaceuticals' myocardial infarction treatment has stalled due to GMP violations of drug developer's contract manufacturer. RegeneRx release

> As part of a rebuilding project that will replace some former Wyeth development labs, Pfizer seeks as many as 80 "redundancy" volunteers for layoff at a Dublin-area plant. Article

> Contract manufacturer JHP Pharmaceuticals says it has signed a multi-year deal with a biotechnology company to produce a sterile liquid product used in processing biologics. JHP release

> In a multi-year supply agreement, Rockwell Medical will provide service and supplies to dialysis provider DaVita. Rockewell release

> India's Union health ministry appears to be neither interested in resuming production of vaccine at the BCG Vaccine Lab in Chennai nor have any plan to support it by granting autonomous status. Story

> Contract manufacturer Almac Pharma Services has expanded its cold storage capacity for biopharmaceuticals. News

Suggested Articles

The FDA has slapped the parent of Dollar Tree stores with a warning letter saying some CMOs that made its OTC products were among the world's worst.

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Continuing its expansion efforts, Japan’s Fujifilm will make a major investment in its U.S. gene therapy operation in Texas.